Testing for biological activity of glucocorticoids and many other steroid endocrine-disrupting chemicals (EDCs) has not been previously performed. An automated, highly reproducible, and low cost assay detects biologically active steroidal EDCs and is suitable for wide application in testing water samples. The National Cancer Institute seeks partners for collaborative co-development research and/or licensing to move this technology into the public domain.
The National Cancer Institute (NCI) seeks research co-development opportunities and/or licensees for a new biomedical device for biopsy tissue collection and storage in a sterile, well-defined environment.
Researchers at the National Cancer Institute (NCI), in collaboration with surgery specialists from Johns Hopkins University, developed hydrogel compositions and methods to suture blood vessels with hydrogels during microsurgery. The hydrogels particularly benefit surgeons in whole tissue transplant procedures. The NCI seeks licensing and/or co-development research collaborations for further development of this technology.